Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.

NCT01694082 · ClinicalTrials.gov registry record · NA

Brief Web-Based Alcohol Reduction Intervention for Undergraduates

A NA study, sponsored by Yale University.

Completed
Registry status
NA
Development phase
207
Enrollment target

NCT01694082: Completed NA study, sponsored by Yale University.

NCT01694082 is a NA study that has completed, run by Yale University. The registered enrollment target is 207 participants, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower). According to ClinicalTrials.gov, the official US trial registry.

View on ClinicalTrials.gov ↗

View your shortlist →

The verdict

NCT01694082, a NA study, has completed, sponsored by Yale University.

COMPLETED
Registry status
NA
Development phase
207 participants
Enrollment target

Study Summary

Tertiary Health Research Intervention Via Email (THRIVE; Kypri et al., 2009), originally utilized with Australian students, is unique in that it contains efficacious components derived from motivational interviewing (e.g., personalized feedback) and cognitive behavioral therapy (protective behavioral strategies), yet is very brief and has established efficacy. This study aims to test versions of THRIVE tailored to American college students. In addition to replicating original results with THRIVE, we will also test versions containing unique subsets of protective behavioral strategies to reduce alcohol consumption. The primary hypothesis is that versions of THRIVE will be associated with lower overall alcohol consumption than an assessment and brief brochure control condition.

Interventions

  • BEHAVIORAL THRIVE
  • BEHAVIORAL Brief brochure and assessment control

Trial Details

FieldValue
Enrollment Target 207 participants
Start Date 2012-10
Est. Completion 2014-06
Phase NA
Yale University

1,492 total trials

What the finished NCT01694082 record still lists

NCT01694082 is an interventional study that assigns participants to a tested intervention. The registered 207 participants enrollment target is mid-sized for trials with a published cap, below the 1,404-participant average among 58,714 other NA trials with a reported enrollment target (85% lower).

The record links to 0 conditions, and to 2 interventions - of which THRIVE is the first listed.

NCT01694082 does not publish any study locations in the registry export this page uses.

Frequently Asked Questions

What is clinical trial NCT01694082 about?

NCT01694082 is a clinical study titled "Brief Web-Based Alcohol Reduction Intervention for Undergraduates". Tertiary Health Research Intervention Via Email (THRIVE; Kypri et al., 2009), originally utilized with Australian students, is unique in that it contains efficacious components derived from motivational interviewing (e.g., personalized feedback) and cognitive behavioral therapy (protective behaviora...

What is the current status of trial NCT01694082?

This trial is currently completed. It is a NA study. The enrollment target is 207 participants. The study started on 2012-10. Estimated completion is 2014-06.

What interventions are being tested in trial NCT01694082?

The interventions under investigation include: THRIVE (BEHAVIORAL), Brief brochure and assessment control (BEHAVIORAL).

Who is sponsoring clinical trial NCT01694082?

This trial is sponsored by Yale University, which has 1,492 total clinical trials registered on ClinicalTrials.gov.

How this trial's enrollment target compares

Where NCT01694082's enrollment target sits among peer trials

207 499th of 2000 higher than 1,502 of 2,000 other NA trials

participants (enrollment target), bucketed by value

Each bar is a band; taller bars hold more other NA trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.

Source ClinicalTrials.gov registry export · 2026-08-08

Nationwide trials with similar profiles

Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.

Similar enrollment target

  • NCT04353778 · 207 participants · Phase 1

    Effects of Vagal Dysfunction on Gastrointestinal and Inflammatory Pathways in HIV

  • NCT05875805 · 207 participants · NA

    A Telehealth Advance Care Planning Intervention

  • NCT06254950 · 207 participants · Phase 2

    A Study on the Safety of TAK-279 and Whether it Can Reduce Inflammation in the Bowel of Participants With Moderately to Severely Active Ulcerative Colitis

  • NCT06904274 · 207 participants · Phase 3

    Mirena for the Treatment of Nonatypical Endometrial Hyperplasia for 6 Months

Similar registry start date

  • NCT05988463 · started 2027-01-01 · Phase 1

    Dose-Escalation Study of Artesunate Patients With IPF

  • NCT07219706 · started 2026-12-10 · NA

    Dietary Fiber and Time Restricted Eating

  • NCT02831335 · started 2026-12-01

    Technical Development of Multi-Parametric Renocerebral MRI

  • NCT05962346 · started 2026-12 · NA

    Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia

Source: ClinicalTrials.gov NCT01694082, the US trial registry maintained by the National Library of Medicine. NCT01694082 (mid enrollment · none site footprint · completed) retrieved and formatted by PlainTrial, see methodology.